LONDON BROKER RATINGS: Citigroup lifts Rightmove and Relx
8th Apr 2026 08:51
(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More
| Price | 95.05p on 20-04-2026 at 18:50:08 |
|---|---|
| Change | -2.85p -2.91% |
| Buy | 95.50p |
| Sell | 95.40p |
| Last Trade: | Buy 44,766.00 at 95.05p |
| Day's Volume: | 9,212,601 |
| Last Close: | 95.05p |
| Open: | 97.10p |
| ISIN: | GB00BYRJ5J14 |
| Day's Range | 95.05p - 97.45p |
| 52wk Range: | 87.40p - 109.50p |
| Market Capitalisation: | £2.47b |
| VWAP: | 95.91581p |
| Shares in Issue: | 2.60b |
Primary Health (PHP) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 44,766 | 95.05p | Automatic Execution |
16:35:26 - 20-Apr-26 |
| Sell* | 1,512 | 95.05p | SI Trade |
16:35:24 - 20-Apr-26 |
| Sell* | 28,907 | 95.05p | SI Trade |
16:35:24 - 20-Apr-26 |
| Sell* | 1 | 95.05p | SI Trade |
16:35:24 - 20-Apr-26 |
| Sell* | 887 | 95.05p | SI Trade |
16:35:24 - 20-Apr-26 |
| Sell* | 6,871 | 95.05p | SI Trade |
16:35:24 - 20-Apr-26 |
| Sell* | 549 | 95.05p | SI Trade |
16:35:24 - 20-Apr-26 |
| Buy* | 2,828,215 | 95.05p | Suspected BUY Trade |
16:35:24 - 20-Apr-26 |
| Sell* | 2,619 | 95.428p | Ordinary |
16:29:50 - 20-Apr-26 |
| Buy* | 2 | 95.50p | SI Trade |
16:29:42 - 20-Apr-26 |
Primary Health (PHP) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 20th Apr 2026 2:00 pm | RNS | Board directorships |
| 25th Mar 2026 1:00 pm | RNS | Issue of shares for Long Term Incentive Plan |
| 25th Mar 2026 7:00 am | RNS | Annual Report 2025 and Notice of 2026 AGM |
| 17th Mar 2026 7:00 am | RNS | Preliminary Results |
| 17th Mar 2026 7:00 am | RNS | Preliminary Results |
| 16th Mar 2026 1:00 pm | RNS | Director/PDMR Shareholding |
| 16th Mar 2026 1:00 pm | RNS | Director/PDMR Shareholding |
| 12th Mar 2026 7:00 am | RNS | Notice of Preliminary Results |
| 11th Mar 2026 8:30 am | RNS | Notice of Interim Dividend |
| 26th Jan 2026 12:30 pm | RNS | Director/PDMR Shareholding |